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Study Design: Retrospective analysis of a nationwide private insurance database. Chi-square analysis and linear regression models 
were utilized for outcome measures. 
Purpose: The purpose of this study was to investigate any relationship between lumbar degenerative disc disease, diabetes, obesity 
and smoking tobacco.
Overview of Literature: Diabetes, obesity, and smoking tobacco are comorbid conditions known to individually have effect on degen-
erative disc disease. Most studies have only been on a small populous scale. No study has yet to investigate the combination of these 
conditions within a large patient cohort nor have they reviewed the combination of these conditions on degenerative disc disease.
Methods: A retrospective analysis of insurance billing codes within the nationwide Humana insurance database was performed, 
using PearlDiver software (PearlDiver, Inc., Fort Wayne, IN, USA), to identify trends among patients diagnosed with lumbar disc de-
generative disease with and without the associated comorbidities of obesity, diabetes, and/or smoking tobacco. Patients billed for 
a comorbidity diagnosis on the same patient record as the lumbar disc degenerative disease diagnosis were compared over time to 
patients billed for lumbar disc degenerative disease without a comorbidity. There were no sources of funding for this manuscript and 
no conflicts of interest.
Results: The total number and prevalence of patients (per 10,000) within the database diagnosed with lumbar disc degenerative dis-
ease increased by 241.4% and 130.3%, respectively. The subsets of patients within this population who were concurrently diagnosed 
with either obesity, diabetes, tobacco use, or a combination thereof, was significantly higher than patients diagnosed with lumbar 
disc degenerative disease alone (p<0.05 for all). The number of patients diagnosed with lumbar disc degenerative disease and smok-
ing rose significantly more than patients diagnosed with lumbar disc degenerative disease and either diabetes or obesity (p<0.05). The 
number of patients diagnosed with lumbar disc degenerative disease, smoking and obesity rose significantly more than the number of 
patients diagnosed with lumbar disc degenerative disease and any other comorbidity alone or combination of comorbidities (p<0.05). 
Conclusions: Diabetes, obesity and cigarette smoking each are significantly associated with an increased diagnosis of lumbar degen-
erative disc disease. The combination of smoking and obesity had a synergistic effect on increased rates of lumbar degenerative disc 
disease. Patient education and preventative care is a vital goal in prevention of degenerative disc disease within the general population.
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Introduction
Low back pain is a major social and economic burden on 
the population, resulting in billions of dollars in payments 
yearly in the United States alone and affecting 15% to 45% 
of the population annually [1-3]. There is a substantial 
number of new diagnoses of back pain yearly and 1% to 
2% of the United States adult population is disabled sec-
ondary to back pain yearly [4-6]. The estimated total cost 
of direct medical expenditures in the United States for 
spine care and related disabilities from spinal pathology in 
2006 was more than $85 billion and the data suggest the 
use and cost of spine care have continued to increase in 
recent years [4-8]. Although the etiology of low back pain 
remains multifactorial, degenerative changes in the inter-
vertebral discs of the spine have been strongly associated 
with the onset of pain [1,9-11].
The World Health Organization defines obesity as a 
body mass index (BMI) of 30 or above [12]. Obesity is a 
serious public health problem worldwide and its preva-
lence is rapidly increasing [7]. Obesity has been shown 
to increase the risks of cardiovascular disease, diabetes, 
osteoarthritis, and spine disease [13-15]. Obesity has been 
implicated as a risk factor of lumbar disc degeneration, 
but previous epidemiological studies have conflicting as-
sociations [16]. 
Diabetes mellitus (DM) is a chronic condition associ-
ated with high blood glucose levels resulting from insulin 
secretory defects and insulin resistance. Elevated glucose 
concentrations have been associated with an increased 
risk of disc degeneration by directly influencing disc cell 
proliferation and survival [17-19].
More than one-third of the population of industrial-
ized countries smoke and in the United States, over 20% 
of the adult population admits to smoking [20]. Highly 
publicized are the respiratory and cardiovascular effects 
of tobacco use, but smoking can cause many orthopaedic 
issues, including delayed fracture-healing, decreased bone 
density, risk of nonunion of fractures and spinal fusions, 
as well as delayed or poor wound healing [21-23].
Intervertebral disc degeneration involves an imbalance 
in anabolic and catabolic activity within the annulus fi-
brosus and nucleus pulposus cells [24-28]. Many factors 
influence the extracellular environment around inter-
vertebral disc cells including nutrient levels, mechanical 
loading, and the chemical environment. Alteration in disc 
cellular viability and activity influences the ability of an-
nulus fibrosus and nucleus pulposus cells to produce ex-
tracellular matrix components and maintain tissue health 
[26].
There have been several studies correlating degenerative 
disc disease to cigarette smoking, obesity or diabetes on a 
microscopic level, but no population level study evaluat-
ing their effect both independently and synergistically.
Materials and Methods
Within the PearlDiver Patient Record Database (PearlDiv-
er Technologies Inc., Warsaw, IN, USA; http://www.pearl-
diverinc.com/), International Classification of Diseases, 
ninth edition (ICD-9) insurance billing codes were used 
to identify the annual trends of patients diagnosed with 
lumbar disc degeneration with and without concurrent 
diagnoses of obesity, diabetes, or tobacco use. We queried 
the subset of patients within the database that is covered 
by Humana (Humana Inc., Louisville, KY, USA; https://
www.humana.com/), a private health insurance company 
that covers nearly 20 million patients across the United 
States.
Codes ICD-9-D-722.73 and ICD-9-D-722.52 were used 
to identify the number of patients diagnosed with lumbar 
disc degenerative disease, with or without myelopathy. 
The lumbar disc degenerative disease population was then 
split into two cohorts: those with concurrent diagnoses of 
tobacco use, diabetes, and/or obesity, and those without 
those diagnoses. To identify patients diagnosed as having 
a tobacco use disorder, ICD-9-D-V15.82, was used. Pa-
tients who were diagnosed with obesity and morbid obe-
sity were identified with the codes ICD-9-D-278.00 and 
ICD-9-D-278.01 and analyzed collectively in a group of 
patients referred to throughout this study simply as obese. 
Finally, patients diagnosed with type 1 or type 2 diabetes, 
controlled or uncontrolled, were identified with codes 
ICD-9-D-250.00, ICD-9-D-250.01, ICD-9-D-250.02, and 
ICD-9-D-250.03. These patients were also analyzed col-
lectively, in a group of patients considered throughout this 
paper simply as diabetic. 
To qualify to be included in the group “lumbar disc 
degenerative disease+obesity,” for example, patients must 
have been diagnosed as obese on the same record as their 
disc degenerative disease diagnosis. To qualify to be in-
cluded in the group “lumbar disc degenerative disease, 
non-obese,” patients could never have been diagnosed 
as obese throughout the entire span of the database. For 
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groups in which patients had multiple concurrent diagno-
ses, such as obesity and diabetes, both of those diagnoses 
similarly had to occur on the same record as the lumbar 
disc degenerative disease diagnosis. Patients can never 
have been diagnosed with either to qualify to be included 
in the analog “non-obese, non-diabetic” group. 
For each of the patient populations described above, we 
tracked the total number of patients who were diagnosed 
with each code from the beginning of 2007 until the end 
of 2014. We compared the trends over time between pa-
tients with and without concurrent diagnoses of tobacco 
use, diabetes, or obesity using chi-squared analysis and 
linear regression. Significance was set at a p-value less 
than 0.05. Demographic information including gender, 
region, race, and age was collected and analyzed as well.
This retrospective cohort study was deemed exempt 
from Institutional Review Board review as all patient in-
formation was de-identified.
Results
From 2007 until 2014, the number of people within the 
Humana database diagnosed with lumbar disc degenera-
tive disease rose 241.1%, from 82,129 to 280,399. When 
adjusted for the growth of population within the database, 
the prevalence per 10,000 patients increased 130.3%, from 
128.63 in 2007 to 296.27 in 2014. The prevalence of males 
and females diagnosed with lumbar disc degenerative 
disease was roughly equivalent from 2007 until the first 
quarter of 2015.
Between patients diagnosed as obese, diabetic, or as 
smokers, smokers were the least prevalent within the da-
tabase. However, smokers increased in prevalence more 
than any of the other populations from 2007 through 
2014, having risen 381.7% from 59.39 to 286.15. The most 
populous age group in this population was between 70 
and 74 years old. 
Patients diagnosed as diabetic were the most preva-
lent but increased in prevalence the least, having risen 
81.1% from 567.78 to 1,028.01 patients per 10,000 from 
2007 through 2014. The prevalence of obese patients rose 
214.1%, from 157.76 to 495.53. For both of these popula-
tions, the most populous age group was 60–64 years old. 
The number of patients diagnosed with the different 
possible combinations of two of the above three condi-
tions also rose measurably between 2007 and 2014. The 
prevalence of patients diagnosed with both smoking and 
obesity on the same record were the least prevalent combi-
nation but increased the most, from 3.66 in 2007 to 25.67 
in 2014—a 601.1% increase. The prevalence of patients 
diagnosed with both obesity and diabetes on the same re-
cord were the most prevalent but increased in prevalence 
the least, from 46.09 in 2007 to 135.94 in 2014—a 195.0% 
increase. The prevalence of patients diagnosed with both 
smoking and diabetes on the same record rose 377.2%, 
from 10.67 out of 10,000 patients in 2007 to 50.92 in 2014.
The raw total number of each of these patient groups 
increased markedly as well, and these results are summa-
rized in Table 1.
Of those patients diagnosed with lumbar disc degenera-
tive disease, two cohorts of patients were analyzed: those 
with a concurrent diagnosis of smoking, diabetes, and/or 
obesity, and those without a concurrent diagnosis (or col-
lection of diagnoses). In every case, patient populations 
with concurrent diagnoses increased in total number and 
in prevalence significantly more than patient populations 
without those diagnoses from 2007 through 2014. 
Patients diagnosed with obesity at the same time as 
their disc degenerative disease diagnosis rose significantly 
more between 2007 and 2014 than did patients who never 
were diagnosed as obese (p<0.05). The prevalence of pa-
tients diagnosed with obesity and lumbar disc degenera-
tive disease rose 517.9%, from 1.22 to 7.54 out of 10,000 
patients (Fig. 1). This increase was nearly five times the 
increase of patients not diagnosed with obesity, whose 
prevalence per 10,000 patients rose 108.0%, from 100.16 
in 2007 to 208.37 in 2014. 
Patients diagnosed as having a tobacco use disorder at 
the same time as their disc degenerative disease diagnosis 
also rose significantly more between 2007 and 2014 than 
patients who were never diagnosed as smokers (p<0.05). 
The prevalence of patients with disc degenerative disease 
who were also smokers rose 627.2% from 2007 to 2014 
(from 0.40 to 2.88 out of 10,000) compared to just 117.6% 
(108.12 to 235.25) for the population never diagnosed 
with smoking (Fig. 2).
Furthermore, the subset of patients diagnosed with 
lumbar disc degenerative disease and diabetes increased 
significantly more than patients diagnosed as having lum-
bar disc degenerative disease but no diabetes (p<0.05). 
The prevalence of patients with a lumbar disc degenera-
tive disease diagnosis but no diabetes diagnoses rose 
126.2% from 80.32 in 2007 to 181.67 in 2014, while the 
number of patients with a concurrent diabetes diagnoses 
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rose 306.4%, from 3.67 to 14.91 out of 10,000, nearly a 
three-fold difference (Fig. 3). Gender appeared to make 
no significant difference on the increase in prevalence 
among the diabetic and non-diabetic patients diagnosed 
with lumbar disc degenerative disease. 
Fig. 1. Incidence of obese vs. non-obese patients with degenerative 
disc disease per 10,000 patients.
Fig. 2. Incidence of patients who smoke vs. non-smokers with degen-
erative disc disease per 10,000 patients.
Fig. 3. Incidence of diabetic vs. non-diabetic patient with degenera-
tive disc disease per 10,000 patients.Ta
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Chi-squared analysis revealed that patients diagnosed 
with lumbar disc degenerative disease and smoking on the 
same record increased significantly more than the num-
ber of patients diagnosed with lumbar disc degenerative 
disease and either obesity or diabetes (p<0.05). Patients 
diagnosed with lumbar disc degenerative disease and 
obesity increased significantly more than the number of 
patients diagnosed with lumbar disc degenerative disease 
and diabetes (p<0.05). 
The data also demonstrates that lumbar disc degenera-
tive disease patients with a combination of comorbid 
diagnoses increased significantly more from 2007 through 
2014 than patients without either of the comorbid diag-
noses. The largest increase in prevalence was seen in the 
patient group diagnosed with lumbar disc degenerative 
disease, obesity, and smoking all within the same pa-
tient record. The prevalence of this population increased 
519.8% from 0.05 patients per 10,000 in 2007 to 0.31 in 
2014 (Fig. 4). The prevalence of patients diagnosed with 
lumbar disc degenerative disease, diabetes, and smoking 
rose 407.7%, from 0.06 to 0.32 patients per 10,000 in the 
database (Fig. 5). Finally, the number of patients diag-
nosed with lumbar disc degenerative disease, obesity, and 
diabetes, increased in prevalence by 374.4%, from 0.25 to 
1.20 (Fig. 6).
The number of patients diagnosed with lumbar disc 
degenerative disease, obesity and smoking increased more 
than patients diagnosed with lumbar disc degenerative 
disease and diabetes (p<0.05). Interestingly, the number 
of patients diagnosed with lumbar disc degenerative dis-
ease, obesity and diabetes increased at a slower rate than 
patients diagnosed with lumbar disc degenerative disease 
and obesity (p<0.05) alone. More, the number of patients 
diagnosed with lumbar disc degenerative disease, smok-
ing, and diabetes increased less than the number patients 
diagnosed with lumbar disc degenerative disease and 
smoking alone (p<0.05). This all suggests that diabetes 
had the least significant effect on the increased prevalence 
rate.
There were 8,683,726 males in the database and 
11,225,017 females in the database. Even after adjusting 
for the difference between males and females in the data-
base, more females were diagnosed with lumbar degener-
ative disc disease per every 10,000 males, there were 440.5 
patients with lumbar disc degenerative disease and per ev-
ery 10,000 females, there were 474.4 patients with lumbar 
disc degenerative disease. Similar trends were true among 
obese patients with lumbar disc degeneration (females 
11.5 to males 8.9 per 10,000). However, the opposite trend 
was true among smokers and diabetic patients, for whom 
Fig. 4. Incidence of obese patients who smoke vs. non-obese, non-
smoking patients with degenerative disc disease per 10,000 patients. 
Fig. 5. Incidence of diabetic patients who smoke vs. non-diabetic, 
non-smoking patients with degenerative disc disease per 10,000 pa-
tients.
Fig. 6. Incidence of diabetic, obese patients with degenerative disc 
disease vs. non-diabetic, non-obese patients with degenerative disc 
disease per 10,000 patients.
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males were more frequent than females. For diabetic pa-
tients, the difference was minimal (females 22.7% to males 
24.6 per 10,000), and for smokers, the difference was most 
pronounced (females 3.4 to males 4.9 per 10,000). 
Ages 65–69 were the most populous cohort of patients 
with lumbar disc degenerative disease (203,660), but after 
adjusting for the number of patients in each age range 
within the entire database, ages 60–64 were the most fre-
quent per 10,000 patients in that age range, followed by 
age 55–59, then 65–69. After adjusting for database de-
mographics, patients aged 60–64 were the most frequently 
diagnosed with smoking, obesity, or diabetes with lumbar 
disc degenerative disease. 
The database consists of many more patients in the 
South than any other region in the United States (North-
east, Midwest, or West), but even after adjusting for the 
number of patients in each region in the database, pa-
tients from the South were most frequently diagnosed 
with lumbar disc degenerative disease (533.7/10,000) and 
patients from the Northwest were diagnosed the least 
(136.0/10,000). Patients from the Northeast were most 
frequently diagnosed with smoking and disc degenera-
tive disease (4.44/10,000), followed closely by the South 
(4.38/10,000). Patients from the South were most fre-
quently diagnosed with smoking or diabetes and lumbar 
disc degenerative disease.
Discussion
Given the significant socioeconomic burden of lower back 
pain on the population and its strong association with in-
tervertebral disc degeneration and disease, there remains 
considerable interest in identifying factors associated with 
the development of this degenerative process [1,9-11]. 
Previous studies have attempted to analyze the link be-
tween lower back pain and various comorbid conditions, 
including smoking [29-31], obesity [32,33], and DM 
[17,18]. These reports range from biomechanical stud-
ies to systematic reviews of the literature. Several larger 
scale studies have attempted to investigate “lower back 
pain” as opposed to the specific diagnosis of “lumbar disc 
degeneration.” To our knowledge, this is the first report to 
analyze the relationship between smoking, diabetes and 
obesity, both independently and synergistically, and the 
development of lumbar disc degenerative disease at the 
epidemiologic level. By inclusion of a very large database 
of almost 20 million patients, we aimed to avoid limita-
tions of previous studies, including low study power and 
the inherent variability in data collection associated with 
systematic review of literature. 
Though the exact pathophysiology of disc degeneration 
continues to be investigated, it has been demonstrated 
that the health of the intervertebral disc is maintained by 
a complex balance of anabolic and catabolic activity with-
in cells of the annulus fibrosis and nucleus pulposus [24-
28]. There currently exist two primary theories regarding 
the mechanism with which tobacco use may contribute to 
intervertebral disc degeneration. The primary proposed 
mechanism involves malnutrition of the disc caused pri-
marily by tobacco-related anoxia and vascular disease. 
Malnutrition of the disc has previously been shown to be 
strongly associated with disc degeneration [31,34] and 
vascular disruption of this nutritional supply is thought to 
play a key role [35-38]. Animal studies have demonstrated 
a reduction in vertebral body blood flow after administra-
tion of nicotine [37-39]. The increased blood concentra-
tion of carbon monoxide in smokers results in a decreased 
oxygen-carrying capacity of hemoglobin and this likely 
represents a further insult to the intervertebral disc’s nu-
tritional pathway [40,41].
Alternatively, it has been proposed that chemical com-
pounds found in cigarette smoke may directly affect cell 
viability and activity in the intervertebral disc [42,43]. 
At the microscopic level, human intervertebral disc cells 
exposed to tobacco smoke demonstrate significant mor-
phologic changes that appear to be dose-dependent [44]. 
Beyond these structural changes, exposure to cigarette 
smoke has been shown to increase cell production of 
interleukin 1β, leading to the upregulation of matrix-
degrading metalloproteinases [26,45,46]. While debate 
continues regarding the exact mechanism of tobacco-
related disc degeneration, evidence suggests a common 
end result. Gross examination of intervertebral disc tissue 
exposed to cigarette smoke demonstrates necrosis and fi-
brosis involving the nucleus pulposus and alteration in the 
layered composition of the annulus fibrosis [38,47]. 
Several reports have demonstrated an association be-
tween smoking and disc degeneration using secondary 
markers, such as radiographic findings or eventual surgi-
cal intervention. Utilizing magnetic resonance imaging 
(MRI), Battie et al. [29] compared the lumbar disc health 
of twenty pairs of identical twins discordant for tobacco 
exposure. With respect to disc height and intensity, the 
authors reported 18% greater mean disc degeneration 
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scores in the smoking group. Of note, these findings were 
consistent throughout the lumbar spine, indicating a sys-
temic effect and decreasing the likelihood of a physical 
loading-related confounding variable. After comparing 
the smoking history of 205 patients that underwent surgi-
cal intervention of cervical or lumbar disc disease with 
an age and sex-matched control population, An et al. [30] 
reported a significantly greater rate of tobacco use in both 
the cervical and lumbar disease group. More recently, 
Mattila et al. [31] reported on a prospective, 11-year fol-
low-up of more than 57,000 adolescents in an attempt to 
identify risk factors for lumbar discectomy in this young 
and relatively healthy population. The authors concluded 
that, with regards to male subjects, daily smoking was the 
strongest risk factor for lumbar discectomy [31]. 
However, not all studies have found a significant corre-
lation between smoking and the development of disc de-
generative disease. Gore at al. [48] compared lateral cervi-
cal radiographs of 50 smokers and 50 non-smokers. The 
study failed to find a statistically significant difference in 
degeneration rates, but the authors admit that plain radi-
ography is not the ideal imaging modality to evaluate disc 
degeneration. After systematic review of 38 epidemiologic 
studies, Goldberg et al. [49] concluded that while there 
exists strong support for the association between smok-
ing and non-specific back pain, too few studies have been 
performed to confidently link smoking with the other 
studied end points, such as disc degeneration, herniation, 
and sciatica. These reports emphasize the difficulty in 
drawing association, let alone causation, in the setting of 
numerous confounding variables. 
Our findings suggest a strong correlation between lum-
bar disc degenerative disease and tobacco use. The preva-
lence of lumbar disc degenerative disease in smokers rose 
627.2%, representing a nearly 6-fold increase compared to 
the non-smoking population. 
Our results support a link between lumbar disc degen-
erative disease and obesity. The prevalence of patients 
with both lumbar DDD and obesity increased more than 
5 times greater than the prevalence of patients with disc 
degenerative disease without obesity. The prevalence of 
obesity is high, exceeding 30% in the United States, and 
remains a major public health issue [50]. “Damaging load-
ing,” perhaps similar to that seen in overweight and obese 
individuals, has been shown to affect intervertebral cell 
viability, synthesis and matrix remodeling [51]. Excessive 
biomechanical loading, as a result of both heavy lifting 
and obesity, has been linked to disc disease and herniation 
[52-55]. Obesity has been referred to as some authors as 
a systemic inflammatory condition, resulting in increased 
inflammatory markers and the development of atheroscle-
rosis [56,57]. This could conceivably represent a vascular 
insult to the intervertebral disc. Early reports, based on 
plain film findings, suggested a possible association be-
tween increased BMI and lumbar degeneration [58]. More 
recently, Samartzis et al. [59] reviewed lumbar MR studies 
of more than 2,500 individuals and reported a significant 
association between the presence, extent and severity of 
disc degenerative changes and increasing body weight. 
Furthermore, obesity may serve as predictor for hospital-
ization secondary to disc disorders [60]. Takatalo et al. [61] 
reported an association between abdominal obesity and 
disc degeneration in 21-year-old males, suggesting a more 
rapid effect than previously thought. However, the exact 
mechanism with which obesity may correlate with disc 
degeneration is poorly understood and other reports have 
failed to independently correlate obesity with disc degen-
eration and disease [33].
Previous studies have suggested that diabetes may nega-
tively affect intervertebral disc health. The accumulation 
of advanced glycation end products in critical disc pro-
teins, such as aggrecan and collagen, results in abnormal 
turnover and increasing non-enzymatic cross-linking [62]. 
Metz et al. [63] revealed a strikingly increased rate of tis-
sue cross-linking in the intervertebral discs of rats with 
increased glycated hemoglobin (HgbA1c) compared to 
a healthy control group. Increased cross-linking leads to 
increased stiffness and brittleness, resulting in an interver-
tebral disc that is may be more susceptible to mechanical 
damage [64,65]. The well-reported microangiopathy asso-
ciated with diabetes likely further diminishes the flow of 
nutrients to the already tenuously supplied intervertebral 
disc [66]. Sakellaridis [18] reported a significantly higher 
rate of diabetes in patients undergoing lumbar discectomy 
compared to patients undergoing elective, non-spine re-
lated interventions. Furthermore, diabetic patients have 
been shown to have significantly decreased disc height, 
in comparison to their non-diabetic counterparts [67]. 
These findings suggest important clinical implications of 
molecular-level changes seen in the diabetic intervertebral 
disc. 
Each co-morbidity was found to have a correlation with 
an increased likelihood for a diagnosis of degenerative 
disc disease, but smoking and obesity were found to have 
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a synergistic effect on the likelihood of degenerative disc 
disease. Videman et al. [55] discovered the combination 
of higher occupational lifting and more smoking during 
follow-up were predictors of increased disc height reduc-
tion in a longitudinal study assessing quantitative MRI 
measures of disc degeneration in middle-aged 134 mono-
zygotic male twins. Leboeuf-Yde et al. [33] evaluated the 
association of self-reported physical hard labor, smoking 
and obesity in four hundred and twelve 40-year old Danes 
with MRI findings, back pain and a vertebral inflamma-
tory process. They found that there were no significant 
associations between the single variables and interverte-
bral disc degeneration. However, they did find that hard 
physical labor in combination with either heavy smoking 
or obesity was strongly associated with a vertebral inflam-
matory process [33].
Limitations of our study include those of any database 
study. There is a possibility of coding bias due to the 
somewhat ambiguous nature of Current Procedural Ter-
minology coding. It is also difficult to know if physicians 
were coding appropriately for lumbar degenerative disc 
disease at the time of the office visit or if the disease had 
been present prior to coding for some time and thus cor-
relation with any of the comorbidities may be miscalcu-
lated. With regards to the limitations of the database used, 
we obtained data from a large private insurer (Humana) 
with customers nationwide, but no other insurers, and the 
Humana patient population may be distinct from other 
insurer’s populations or the uninsured.
Conclusions
This study confirms, on a large scale patient population 
model, that diabetes, obesity and cigarette smoking each 
are significantly associated with an increased diagnosis of 
lumbar degenerative disc disease. Previous literature had 
found that correlation on a smaller population level and 
only individually among the comorbidities. This study 
also discovered that the combination of these morbidities 
either in different pairings or all three had a synergistic 
effect on increased rates of lumbar degenerative disc 
disease. Smoking and obesity, above all, had the highest 
impact and most dramatic synergistic effect leading to in-
creased rates of lumbar degenerative disc disease. Future 
studies will need to correlate these risk factors further and 
potentially will involve prospective studies. Nevertheless, 
this study is a lead in to support the idea of patient educa-
tion and preventative care as having a potential impact in 
prevention of degenerative disc disease within the general 
population. 
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